RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in ...
Nektar Therapeutics reported Phase 2b alopecia areata data showing hair regrowth trends, narrowly missing significance before ...
In the HARMONY Alliance Study of European randomized clinical trials, researchers sought to determine if MRD could serve as an intermediate endpoint in intensively treated AML.
Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
SAN FRANCISCO -- Men with advanced prostate cancer and limited metastatic recurrence lived more than twice as long without disease progression when they received metastasis-directed radioactive ...
The TULIP-SC trial evaluated the efficacy and safety of the subcutaneous administration of SAPHNELO compared to placebo in participants with moderately to severely active, autoantibody-positive SLE, ...
A phase 2a trial of Rapport Therapeutics’ focal onset seizure drug candidate has hit its primary endpoint, sending shares in the biotech up more than 157% in premarket trading. The study enrolled 30 ...
Study Also Reveals $4.5 Million in Quantified Benefits Over Three Years With Payback in Under Six Months for Organizations Endpoint Central helps streamline IT operations, enhancing endpoint security, ...
This guide shows configure and deploy Microsoft Defender for Endpoint to better protect your company from cyber threats. By adding your devices, you can find and stop threats faster and keep your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results